John M. Ashton

Gene sets identified with oncogene cooperativity analysis regulate in vivo growth and survival of leukemia stem cells.

BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells.

Residual Disease in a Novel Xenograft Model of RUNX1-Mutated, Cytogenetically Normal Acute Myeloid Leukemia.

Leukemic Stem Cells Evade Chemotherapy by Metabolic Adaptation to an Adipose Tissue Niche.

Evolution of acute myelogenous leukemia stem cell properties following treatment and progression.

Targeted therapy for a subset of acute myeloid leukemias that lack expression of aldehyde dehydrogenase 1A1.

Developmental alcohol exposure impairs synaptic plasticity without overtly altering microglial function in mouse visual cortex.

Index case of acute myeloid leukemia in a family harboring a novel germ line mutation.

T cell developmental arrest in former premature infants increases risk of respiratory morbidity later in infancy.

Targeting the gut microbiome to treat the osteoarthritis of obesity.

ARID1A, a SWI/SNF subunit, is critical to acinar cell homeostasis and regeneration and is a barrier to transformation and epithelial-mesenchymal transition in the pancreas.

Decellularized Wharton jelly matrix: a biomimetic scaffold for ex vivo hematopoietic stem cell culture.

A Review of the Scientific Rigor, Reproducibility, and Transparency Studies Conducted by the ABRF Research Groups.

Scaffold-mediated CRISPR-Cas9 delivery system for acute myeloid leukemia therapy.

Altered TGFB1 regulated pathways promote accelerated tendon healing in the superhealer MRL/MpJ mouse.

Identification of a Vitamin-D Receptor Antagonist, MeTC7, which Inhibits the Growth of Xenograft and Transgenic Tumors .

Comparative Analysis of Single-Cell RNA Sequencing Platforms and Methods.